Overview / Abstract: |
Target Audience Program Overview In this module, we will compare the mechanism of action of monoclonal and polyclonal antibodies and evaluate clinical trial evidence on the efficacy and safety of these therapies for the management of COVID-19. Learning Objective Differentiate between polyclonal and monoclonal antibody therapies and evaluate clinical trial data on the efficacy and safety of these treatments |
Expiration |
Feb 08, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.5 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Shyam Kottilil MD, PhD |
Sponsors / Supporters / Grant Providers |
Regeneron Pharmaceuticals, Inc. |
Keywords / Search Terms |
Relias LLC Relias, Free CME, COVID-19 Free CE CME |